MEMO THERAPEUTICS

memo-therapeutics-logo

Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis. Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’s immune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery. MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.

#SimilarOrganizations #People #Financial #Website #More

MEMO THERAPEUTICS

Social Links:

Industry:
Biotechnology Collaboration

Founded:
2012-01-01

Address:
Schlieren, Zurich, Switzerland

Country:
Switzerland

Website Url:
http://www.memo-therapeutics.com

Total Employee:
1+

Status:
Active

Contact:
+41 44 515 91 40

Email Addresses:
[email protected]

Total Funding:
59.15 M USD

Technology used in webpage:
IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail ReCAPTCHA


Similar Organizations

adrestia-therapeutics-logo

Adrestia Therapeutics

Adrestia is developing therapeutics that work in an entirely new way – restoring the biological balance in damaged, diseased or dying cells

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

amsterdam-scientific-instruments-logo

Amsterdam Scientific Instruments

Amsterdam Scientific Instruments specializes in the fields of neutron detection, electron imaging, and X-ray detector technology.

anocca-ab-logo

Anocca AB

Anocca AB provides services like Biotechnology, Immunotherapeutics, Drug Discovery, Drug Development, Immunology.

apheabio-logo

Aphea.Bio

Aphea.Bio offers research and development in the areas of bioinsecticides and bioherbicides.

biot-logo

BIOT

BIOT is dedicated to research and innovation in the field of microbiology and biotechnology.

bluu-seafood-logo

Bluu Seafood

Bluu Seafood Provides Sea Food Manufacturing Services.

celtic-renewables-logo

Celtic Renewables

Celtic Renewables is a biofuel startup focused on the renewable energy and whisky sector.

domainex-logo

Domainex

A fully integrated drug discovery service company.

emmac-life-sciences-logo

EMMAC Life Sciences

EMMAC is a medical cannabis company that works to join together the latest science and research with cutting-edge cultivation.

ethris-logo

ETHRIS

ETHRIS is a technical innovator in the emerging field of mRNA therapeutics and LNP delivery.

evariste-technologies-logo

Evariste Technologies

Biotech using quantitative modelling to make drug discovery more efficient

genomesio-logo

genomes.io

genomes.io is a human genome is the blueprint to what makes you who you are.

hoxton-farms-logo

Hoxton Farms

Based in London, UK, Hoxton Farms is growing cultivated fat as an ingredient for the meat alternatives industry.

imvaq-therapeutics-logo

IMVAQ Therapeutics

Imvaq Therapeutics is an innovative cancer immunotherapy company.

infinited-fiber-company-logo

Infinited Fiber Company

Infinited Fiber Company is on a mission to make circular fashion and textiles an everyday reality

kymira-sport-logo

KYMIRA Sport

KYMIRA Sport is developing a range of performance and recovery enhancing sportswear.

leucid-bio-logo

Leucid Bio

Leucid is progressing novel cart therapies that produce a better and more durable response.

mnemo-therapeutics-logo

Mnemo Therapeutics

Mnemo Therapeutics specializes in biotechnology and life science.

orf-genetics-logo

ORF Genetics

ORF Genetics is an innovative company that is committed to economically viable and enabling solutions.

pandion-therapeutics-logo

Pandion Therapeutics

Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.

pats-logo

PATS

PATS is an Indoor Drone Solutions enables greenhouse farmers to significantly reduce and eliminate flying insect pest populations

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

stipe-therapeutics-logo

STipe Therapeutics

STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.

not_available_image

Telomere Therapeutics

Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis


Current Advisors List

michael-sidler_image

Michael Sidler Member of the board @ Memo Therapeutics
Board_member
2015-01-01

christian-schneider_image

Christian Schneider Board of Director @ Memo Therapeutics
Board_member
2022-02-16

philippe-dro_image

Philippe Dro Board of Director @ Memo Therapeutics
Board_member
2022-02-16

andreas-wüpper_image

Andreas Wüpper Board of Director @ Memo Therapeutics
Board_member
2022-02-16

Current Employees Featured

not_available_image

Christoph Esslinger
Christoph Esslinger Founder & CEO @ Memo Therapeutics
Founder & CEO

Founder


not_available_image

Christoph Esslinger

Investors List

verve-ventures_image

Verve Ventures

Verve Ventures investment in Series B - Memo Therapeutics

fresenius-medical-care_image

Fresenius Medical Care

Fresenius Medical Care investment in Series B - Memo Therapeutics

zürcher-kantonalbank_image

Zürcher Kantonal Bank

Zürcher Kantonal Bank investment in Series B - Memo Therapeutics

vesalius-biocapital-partners_image

Vesalius Biocapital Partners

Vesalius Biocapital Partners investment in Series B - Memo Therapeutics

adjuvant-capital_image

Adjuvant Capital

Adjuvant Capital investment in Series B - Memo Therapeutics

gf-group-holding_image

GF Group Holding

GF Group Holding investment in Series B - Memo Therapeutics

swisscanto-invest_image

Swisscanto Private Equity

Swisscanto Private Equity investment in Series B - Memo Therapeutics

federal-office-of-public-health-foph-switzerland_image

Federal Office of Public Health (FOPH) Switzerland

Federal Office of Public Health (FOPH) Switzerland investment in Grant - Memo Therapeutics

bernina-bioinvest_image

Bernina BioInvest

Bernina BioInvest investment in Series B - Memo Therapeutics

redalpine-venture-partners_image

Redalpine

Redalpine investment in Series B - Memo Therapeutics

Official Site Inspections

http://www.memo-therapeutics.com

  • Host name: 185-151-30-220.ptr4.stackcp.net
  • IP address: 185.151.30.220
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "Memo Therapeutics" on Search Engine